23 Daily — On November 6, 2026, BioMap, a foundational large-model company in life sciences, hosted the 3rd International Bio-Computing Innovation Summit 2026 at the Hong Kong Convention and Exhibition Centre, supported by Hong Kong Investment Management Limited. The summit gathered around 300 representatives from the research, industry, and investment sectors to discuss the integration of artificial intelligence (AI) with life sciences. During the event, BioMap announced strategic partnerships with 11 universities, research institutions, and enterprises, advancing AI applications in new drug development, traditional Chinese medicine research, and agricultural breeding. These collaborations include projects like the breast cancer virtual cell large model, AI-TCM joint laboratory, and AI-based breeding platforms, supporting translational research and international expansion. Source: according to leiphone.com.
BioMap and Partners Advance AI Bio-Computing Research
At the summit's launch ceremony, BioMap's InnoHub announced collaborations with 11 partners, including the University of Hong Kong, Hong Kong Baptist University, research enterprises, and investment institutions. The projects involve establishing a breast cancer virtual cell large model, initiating an AI-enabled Traditional Chinese Medicine joint laboratory, and developing AI-driven agricultural breeding platforms. The cooperative network extends beyond Hong Kong to Japan, Singapore, and Belt and Road countries, aiming to enhance pharmaceutical R&D efficiency and industrial upgrades through AI bio-computing technologies.
Hong Kong Government and Investment Firm Back Research Commercialization
Finance Secretary Paul Chan highlighted how AI and bio-computing advances offer opportunities to reduce new drug development timelines and costs. He emphasized the necessity of rigorous clinical validation to translate research breakthroughs into safe and effective therapies. The government plans to strengthen clinical research and regulatory capabilities in collaboration with Shenzhen-Hong Kong cooperation zones and leverage Hong Kong's status as an international financial center to attract global pharmaceutical, tech companies, and investors. Christine Chen, CEO of Hong Kong Investment Management Limited, stressed the long R&D cycles in life sciences and the importance of sustained collaboration among government, industry, academia, research, and investment sectors. The partnership between Hong Kong Investment Limited and BioMap exemplifies how financial capital supports research translation.
Diverse Topics and Global Cooperation Drive Life Science Progress
The summit featured academic talks and panel discussions covering world-scale AI models, wearable biosensors, embodied intelligence, the development of bio-computing in Hong Kong, biomedical AI R&D, investment, and international market expansion. BioMap co-founder and CEO You Wei stated that Hong Kong serves as a critical hub linking global research, industry, and capital. The company will continue to deepen cross-border R&D collaboration, invest in experimental validation and enterprise incubation, aiming to transition AI design projects towards product development and commercial applications.
Editor's take: AI-Life Science Partnerships Unlock Innovation Opportunities
BioMap's multi-institutional collaboration reflects the expanding breadth and depth of AI applications across life sciences, including breast cancer, Traditional Chinese Medicine, and agricultural breeding. The active support from the Hong Kong government and investment entities helps to bridge capital with research commercialization, accelerating product market entry and driving industrial upgrading. For entrepreneurs, the growing AI-life science research platforms, international partnerships, and patient capital sources provide fertile grounds for startup development. Validation of these trends can focus on the maturity of collaborative technologies, clinical trial progress, and success in cross-border market expansion, as well as the cultivation of related industrial ecosystems.